Ipsen has expanded its oncology pipeline by licensing rights to an antibody-drug conjugate (ADC) for solid tumours from Sutro Biopharma, its first drug in the category. The deal, which has a top ...
It took clutch 3-point making and a little bit of magic for Santa Barbara to take down juggernaut Mater Dei Tuesday night.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback